These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 8923853

  • 21. Body proportions during long-term growth hormone treatment in girls with Turner syndrome participating in a randomized dose-response trial.
    Sas TC, Gerver WJ, de Bruin R, Stijnen T, de Muinck Keizer-Schrama SM, Cole TJ, van Teunenbroek A, Drop SL.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4622-8. PubMed ID: 10599729
    [Abstract] [Full Text] [Related]

  • 22. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [Abstract] [Full Text] [Related]

  • 23. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
    Quigley CA, Crowe BJ, Anglin DG, Chipman JJ.
    J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
    [Abstract] [Full Text] [Related]

  • 24. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial.
    Davenport ML, Crowe BJ, Travers SH, Rubin K, Ross JL, Fechner PY, Gunther DF, Liu C, Geffner ME, Thrailkill K, Huseman C, Zagar AJ, Quigley CA.
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3406-16. PubMed ID: 17595258
    [Abstract] [Full Text] [Related]

  • 25. Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.
    Kriström B, Jansson C, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2889-98. PubMed ID: 9284715
    [Abstract] [Full Text] [Related]

  • 26. Final height in Turner syndrome patients treated with growth hormone.
    Pasquino AM, Passeri F, Municchi G, Segni M, Pucarelli I, Larizza D, Bossi G, Severi F, Galasso C.
    Horm Res; 1996 Sep; 46(6):269-72. PubMed ID: 8982737
    [Abstract] [Full Text] [Related]

  • 27. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC, Stijnen T, De Jong MC, Donckerwolcke RA, De Muinck Keizer-Schrama SM, Blum WF, Drop SL.
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [Abstract] [Full Text] [Related]

  • 28. The correlation of the IGF-I, IGFBP-3, and ALS generation test to height velocity after 6 months of recombinant growth hormone therapy in girls with Turner syndrome.
    Collett-Solberg PF, Pessoa de Queiroz AN, Cardoso ME, Jusan RC, Vaisman M, Guimarães MM.
    Growth Horm IGF Res; 2006 Aug; 16(4):240-6. PubMed ID: 16908209
    [Abstract] [Full Text] [Related]

  • 29. Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. Dutch Advisory Group on Growth Hormone.
    Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Aanstoot HJ, Drop SL.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):769-75. PubMed ID: 10690889
    [Abstract] [Full Text] [Related]

  • 30. Adult height in sixty girls with Turner syndrome treated with growth hormone matched with an untreated group.
    Pasquino AM, Pucarelli I, Segni M, Tarani L, Calcaterra V, Larizza D.
    J Endocrinol Invest; 2005 Apr; 28(4):350-6. PubMed ID: 15966509
    [Abstract] [Full Text] [Related]

  • 31. Growth promotion and Turner-specific bone age after therapy with growth hormone and in combination with oxandrolone: when should therapy be started in Turner syndrome?
    Joss EE, Mullis PE, Werder EA, Partsch CJ, Sippell WG.
    Horm Res; 1997 Apr; 47(3):102-9. PubMed ID: 9050948
    [Abstract] [Full Text] [Related]

  • 32. Analyses from a centre of short- and long-term growth in Turner's syndrome on standard growth hormone doses confirm growth prediction algorithms and show normal IGF-I levels.
    Ranke MB, Schweizer R, Martin DD, Ehehalt S, Schwarze CP, Serra F, Binder G.
    Horm Res Paediatr; 2012 Apr; 77(4):214-21. PubMed ID: 22433161
    [Abstract] [Full Text] [Related]

  • 33. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM, Pucarelli I, Roggini M, Segni M.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [Abstract] [Full Text] [Related]

  • 34. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome.
    Van Pareren YK, De Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Drop SL.
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5442-8. PubMed ID: 12466334
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
    Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen M, Delemarre-van de Waal HA, Stokvis-Brantsma WH, Waelkens JJ, Westerlaken C, Reeser HM, van Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM.
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
    [Abstract] [Full Text] [Related]

  • 36. Growth and Adult Height in Girls With Turner Syndrome Following IGF-1 Titrated Growth Hormone Treatment.
    Cleemann Wang A, Hagen CP, Nedaeifard L, Juul A, Jensen RB.
    J Clin Endocrinol Metab; 2020 Aug 01; 105(8):. PubMed ID: 32421787
    [Abstract] [Full Text] [Related]

  • 37. [Prediction of final height in girls with Turner syndrome treated with growth hormone].
    Morin A, Guimarey L, Santucci Z, Apezteguia M.
    Medicina (B Aires); 2000 Aug 01; 60(5 Pt 1):551-4. PubMed ID: 11188890
    [Abstract] [Full Text] [Related]

  • 38. Influence of hormonal therapy on growth rate and bone age progression in patients with Turner syndrome.
    Gawlik A, Gawlik T, Koehler B, Malecka-Tendera E, Augustyn M, Woska W.
    Endokrynol Pol; 2005 Aug 01; 56(2):136-44. PubMed ID: 16335681
    [Abstract] [Full Text] [Related]

  • 39. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
    Sass TC, De Muinck Keizer-Schrama SM, Stijnen T, Asarfi A, Van Leeuwen WJ, Van Teunenbroek A, Van Rijn RR, Drop SL.
    Clin Endocrinol (Oxf); 2000 May 01; 52(5):531-6. PubMed ID: 10792330
    [Abstract] [Full Text] [Related]

  • 40. Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, Mouton JW, Blum WF, Mercado M, Baumann G, Drop SL.
    Clin Endocrinol (Oxf); 1993 Jul 01; 39(1):77-84. PubMed ID: 7688672
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.